首页 > 最新文献

Lymphology最新文献

英文 中文
Does Liposuction for Lymphedema Worsen Lymphatic Injury? 吸脂治疗淋巴水肿会加重淋巴损伤吗?
Pub Date : 2023-01-01
W F Chen, S K Pandey, J N Lensing

Liposuction for treatment of lymphedema is an effective and time-tested treatment. However, as there is a fear regarding further lymphatic damage caused by liposuction, we objectively compared lymphatic function pre- and post-liposuction. All patients with solid-predominant lymphedema who were treated during the study period of June 2014 and November 2018 were included. Patients were assessed using patient-reported baselines/outcomes, lymphedema- specific quality of life scale (LYMQOL), limb circumference/volume measurements, and indocyanine green lymphography (ICGL) preoperatively and at predefined postoperative time intervals. Fifty-seven limbs from 41 patients were included. Mean lipoaspirate volumes were 2035 mL, 5385 mL, and 3106 mL for the arm, thigh, and leg, respectively with a mean adipose fraction of the lipoaspirate of 71%. All patients underwent redundant skin excision with the "flying squirrel" technique. The mean follow-up was 10.7 months (range 3 - 48 months) with a mean limb volume reduction of 32.2% and all patients reporting satisfactory relief of symptoms. All showed statistically significant improvement in LYMQOL in symptoms, appearance, and function. On ICGL, none showed worsened lymphatic drainage, rather, all showed improved lymph drainage. Furthermore, the improved lymph drainage was found to be progressive during the study period in all patients. Our study results demonstrate that treating extremity lymphedema with liposuction does not worsen lymphatic function and in fact, paradoxically, it induces progressive improvement in lymph drainage.

吸脂治疗淋巴水肿是一种有效且久经考验的治疗方法。然而,由于担心吸脂会进一步损害淋巴,我们客观地比较了吸脂前后的淋巴功能。研究纳入了2014年6月至2018年11月期间接受治疗的所有固态淋巴水肿患者。使用患者报告的基线/结果、淋巴水肿特异性生活质量量表(LYMQOL)、肢体围度/体积测量和吲哚菁绿淋巴造像(ICGL)进行术前和术后预先确定的时间间隔评估患者。纳入41例患者的57条肢体。手臂、大腿和腿部的平均吸脂量分别为2035 mL、5385 mL和3106 mL,吸脂量的平均脂肪含量为71%。所有患者均采用“鼯鼠”技术进行皮肤切除。平均随访时间为10.7个月(3 - 48个月),平均肢体体积缩小32.2%,所有患者均报告症状得到满意缓解。所有患者的症状、外观和功能均有统计学上的显著改善。在ICGL上,没有人表现出淋巴引流恶化,相反,所有人都表现出淋巴引流改善。此外,在研究期间,所有患者的淋巴引流改善都是进行性的。我们的研究结果表明,用吸脂术治疗四肢淋巴水肿不会使淋巴功能恶化,事实上,矛盾的是,它会诱导淋巴引流的进行性改善。
{"title":"Does Liposuction for Lymphedema Worsen Lymphatic Injury?","authors":"W F Chen, S K Pandey, J N Lensing","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Liposuction for treatment of lymphedema is an effective and time-tested treatment. However, as there is a fear regarding further lymphatic damage caused by liposuction, we objectively compared lymphatic function pre- and post-liposuction. All patients with solid-predominant lymphedema who were treated during the study period of June 2014 and November 2018 were included. Patients were assessed using patient-reported baselines/outcomes, lymphedema- specific quality of life scale (LYMQOL), limb circumference/volume measurements, and indocyanine green lymphography (ICGL) preoperatively and at predefined postoperative time intervals. Fifty-seven limbs from 41 patients were included. Mean lipoaspirate volumes were 2035 mL, 5385 mL, and 3106 mL for the arm, thigh, and leg, respectively with a mean adipose fraction of the lipoaspirate of 71%. All patients underwent redundant skin excision with the \"flying squirrel\" technique. The mean follow-up was 10.7 months (range 3 - 48 months) with a mean limb volume reduction of 32.2% and all patients reporting satisfactory relief of symptoms. All showed statistically significant improvement in LYMQOL in symptoms, appearance, and function. On ICGL, none showed worsened lymphatic drainage, rather, all showed improved lymph drainage. Furthermore, the improved lymph drainage was found to be progressive during the study period in all patients. Our study results demonstrate that treating extremity lymphedema with liposuction does not worsen lymphatic function and in fact, paradoxically, it induces progressive improvement in lymph drainage.</p>","PeriodicalId":94343,"journal":{"name":"Lymphology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Re-Discovery of Dural (Meningeal) Lymphatics: Amnesia or Ambition? 硬膜(脑膜)淋巴管的重新发现:健忘症还是雄心?
Pub Date : 2023-01-01
R P Erickson

In 2015 the discovery of meningeal (dural) lymphatics was announced to much fanfare. The journal Science named this the second most important discovery of the year! Yet, they had actually been well described two and a quarter centuries earlier, in Italy, England, and Holland. However, there was controversy about their existence because of the difficulties in studying them, also addressed two and a quarter centuries earlier. Their study had generated a very large literature and they were "textbook" knowledge. The reasons for this neglect are discussed emphasizing the current scientific milieu and the changing modes of evaluating scientists.

2015 年,脑膜(硬脑膜)淋巴管的发现被大肆宣扬。科学》(Science)杂志将其评为年度第二大重要发现!然而,其实早在两个又四分之一世纪之前,意大利、英国和荷兰就已经对它们进行了详细描述。然而,由于对它们的研究困难重重,人们对它们的存在存在争议,这也是在两个又四分之一世纪之前解决的。对它们的研究产生了大量的文献,它们是 "教科书 "上的知识。我们讨论了这种忽视的原因,强调了当前的科学环境和不断变化的科学家评价模式。
{"title":"The Re-Discovery of Dural (Meningeal) Lymphatics: Amnesia or Ambition?","authors":"R P Erickson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In 2015 the discovery of meningeal (dural) lymphatics was announced to much fanfare. The journal Science named this the second most important discovery of the year! Yet, they had actually been well described two and a quarter centuries earlier, in Italy, England, and Holland. However, there was controversy about their existence because of the difficulties in studying them, also addressed two and a quarter centuries earlier. Their study had generated a very large literature and they were \"textbook\" knowledge. The reasons for this neglect are discussed emphasizing the current scientific milieu and the changing modes of evaluating scientists.</p>","PeriodicalId":94343,"journal":{"name":"Lymphology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141428649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Handley's Thread Lymphangioplasty Vs. BioBridgetm Collagen Matrix for Lymphedema Therapy - Old Wine in New Bottles? 汉德利线淋巴管成形术与用于淋巴水肿治疗的 BioBridgetm 胶原蛋白基质--新瓶装旧酒?
Pub Date : 2023-01-01
M Witt, A Ring

Lymphangioplasty is a technique of reconstructive lymphatic surgery where subcutaneous lymphatic neocollectors are created, using surgical threads, nanofibrillar collagen threads, plastic tubes or autologous tissue flaps. The history and success rates of these techniques are outlined and a classification for lymphangioplasty techniques is proposed. The use of absorbable surgical threads is suggested for modern attempts of thread lymphangioplasties. The results of such a thread lymphangioplasty should be compared with that of implanted nanofibrillar collagen threads or plastic tubes in order to evaluate whether the technique itself or the material used is responsible for the therapeutic success.

淋巴管成形术是一种淋巴重建手术技术,利用手术线、纳米纤维胶原线、塑料管或自体组织瓣创建皮下淋巴新收集器。本文概述了这些技术的历史和成功率,并提出了淋巴管成形术的分类方法。建议现代淋巴管成形术尝试使用可吸收手术线。应将这种线状淋巴管成形术的结果与植入纳米纤维胶原线或塑料管的结果进行比较,以评估是技术本身还是所用材料导致了治疗的成功。
{"title":"Handley's Thread Lymphangioplasty Vs. BioBridge<sup>tm</sup> Collagen Matrix for Lymphedema Therapy - Old Wine in New Bottles?","authors":"M Witt, A Ring","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Lymphangioplasty is a technique of reconstructive lymphatic surgery where subcutaneous lymphatic neocollectors are created, using surgical threads, nanofibrillar collagen threads, plastic tubes or autologous tissue flaps. The history and success rates of these techniques are outlined and a classification for lymphangioplasty techniques is proposed. The use of absorbable surgical threads is suggested for modern attempts of thread lymphangioplasties. The results of such a thread lymphangioplasty should be compared with that of implanted nanofibrillar collagen threads or plastic tubes in order to evaluate whether the technique itself or the material used is responsible for the therapeutic success.</p>","PeriodicalId":94343,"journal":{"name":"Lymphology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141428646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Lymphedema Using Large Data Sets: An Epidemiological Analysis in the United States and in Italy. 利用大型数据集了解淋巴水肿的流行情况:美国和意大利的流行病学分析。
Pub Date : 2023-01-01
A Grigorean, D Voci, I T Farmakis, L Hobohm, K Keller, N Kucher, I Luchsinger, E Micieli, E Schievano, S Barco, U Fedeli

There is a lack of large epidemiological studies focusing on the prevalence of lymphedema. Vital registration data from the United States (US) (1999-2020) and Veneto, Italy (2008-2021) were analyzed. Lymphedema-related deaths were identified using disease-specific ICD-10 codes and served to estimate the burden of disease in the general population. We studied (i) the lymphedema-specific proportionate mortality as a proxy of the disease-specific prevalence, (ii) the prevalence of lymphedema in key patient subgroups, and (iii) age and sex-specific mortality rates. The prevalence of lymphedema increased over the last two decades with marked sex-specific differences: in the US, the estimated prevalence of lymphedema was 2.7 per 10,000 deaths for women and 1.5 per 10,000 deaths for men. In Veneto, the prevalence was 3.0 per 10,000 deaths for women and 1.1 per 10,000 deaths for men. The prevalence of lymphedema was 2- to 20-times in specific subgroups of patients, including those with obesity, skin infections, hypertension, diabetes mellitus, breast/gynecological cancers, and venous thromboembolism. The estimated prevalence of lymphedema is 2- to 3-times higher than previously thought and has been increasing for the past two decades. These results will serve as a reference for future research in this field.

目前还缺乏针对淋巴水肿患病率的大型流行病学研究。本文分析了美国(1999-2020 年)和意大利威尼托(2008-2021 年)的生命登记数据。我们使用疾病特异性 ICD-10 编码确定了与淋巴水肿相关的死亡病例,并以此估算了普通人群的疾病负担。我们研究了(i)淋巴水肿特异性比例死亡率作为疾病特异性患病率的替代指标,(ii)淋巴水肿在主要患者亚群中的患病率,以及(iii)年龄和性别特异性死亡率。在过去二十年中,淋巴水肿的患病率有所上升,但性别差异明显:在美国,淋巴水肿的患病率估计为女性每万例死亡中有 2.7 例,男性每万例死亡中有 1.5 例。在威尼托(Veneto),女性的发病率为每 10,000 例死亡中有 3.0 例淋巴水肿,男性为每 10,000 例死亡中有 1.1 例淋巴水肿。在特定的亚组患者中,淋巴水肿的发病率是其他患者的 2 到 20 倍,包括肥胖、皮肤感染、高血压、糖尿病、乳腺癌/妇科癌症和静脉血栓栓塞症患者。据估计,淋巴水肿的发病率比以前认为的高出 2 到 3 倍,并且在过去 20 年中一直呈上升趋势。这些结果将为该领域未来的研究提供参考。
{"title":"Prevalence of Lymphedema Using Large Data Sets: An Epidemiological Analysis in the United States and in Italy.","authors":"A Grigorean, D Voci, I T Farmakis, L Hobohm, K Keller, N Kucher, I Luchsinger, E Micieli, E Schievano, S Barco, U Fedeli","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>There is a lack of large epidemiological studies focusing on the prevalence of lymphedema. Vital registration data from the United States (US) (1999-2020) and Veneto, Italy (2008-2021) were analyzed. Lymphedema-related deaths were identified using disease-specific ICD-10 codes and served to estimate the burden of disease in the general population. We studied (i) the lymphedema-specific proportionate mortality as a proxy of the disease-specific prevalence, (ii) the prevalence of lymphedema in key patient subgroups, and (iii) age and sex-specific mortality rates. The prevalence of lymphedema increased over the last two decades with marked sex-specific differences: in the US, the estimated prevalence of lymphedema was 2.7 per 10,000 deaths for women and 1.5 per 10,000 deaths for men. In Veneto, the prevalence was 3.0 per 10,000 deaths for women and 1.1 per 10,000 deaths for men. The prevalence of lymphedema was 2- to 20-times in specific subgroups of patients, including those with obesity, skin infections, hypertension, diabetes mellitus, breast/gynecological cancers, and venous thromboembolism. The estimated prevalence of lymphedema is 2- to 3-times higher than previously thought and has been increasing for the past two decades. These results will serve as a reference for future research in this field.</p>","PeriodicalId":94343,"journal":{"name":"Lymphology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Updated Classification of Primary Lymphedema Based on Age of Onset, Lymphatic Anomalies, and Genetics. 基于发病年龄、淋巴异常和遗传的原发性淋巴水肿最新分类。
Pub Date : 2023-01-01
N F Liu, M Z Gao, P E Maltese, M Bertelli

Primary lymphedema (PLE) is a chronic disease caused by lymphatic dysplasia and progresses to irreversible tissue edema and hypertrophy. Understanding of PLE has been hitherto limited. The aim of this study is to devise an updated classification system for PLE of 1013 patients with PLE of lower limb were enrolled. Sex, age of onset, location, family history and morbidity were documented. The lymphatic imaging findings of magnetic reso-nance lymphography (MRL), indocyanine green lymphography (ICGL) and lymphoscin-tigraphy (LSG), skin tissue immunohisto-chemical staining, whole exome sequencing and the correlation of genotype-phenotype were evaluated. Patients were divided into a congenital onset category and a late onset category. The late onset category was further divided according to developmental age. The ratio of congenital-onset to late-onset PLE was 1:4 and that the highest incidence was in adolescence. The sex ratio was 1.04:1 and 1.5:1 in congenital-onset and late-onset groups, respectively. Three major lymphatic anomalies were identified, in which segmental lymphatic dysfunction, characterized by delayed or partial demonstration of lymph vessels, is the most common and associated with FLT4, GJC2, CELSR1, and PTPN14 mutations. The next most common type is lymphatic hyperplasia, which is associated with FOXC2 and GATA2 variants, followed by initial lymphatic aplasia or dysfunction, which is more common in pa-tients with congenital PLE and associated with FLT4 mutation. A functional and structural combined classification of lymphatic anomalies is proposed, which includes segmental lymphatic dysfunction, lymphatic hyperplasia and initial lymphatic aplasia or dysfunction.

原发性淋巴水肿(PLE)是一种由淋巴发育不良引起的慢性疾病,会发展为不可逆转的组织水肿和肥大。迄今为止,人们对原发性淋巴水肿的了解还很有限。本研究的目的是为下肢淋巴结肿大性水肿设计一个最新的分类系统,共纳入 1013 名下肢淋巴结肿大性水肿患者。研究记录了患者的性别、发病年龄、部位、家族史和发病率。评估了磁共振淋巴造影(MRL)、吲哚菁绿淋巴造影(ICGL)和淋巴霉素造影(LSG)的淋巴成像结果、皮肤组织免疫组织化学染色、全外显子组测序以及基因型与表型的相关性。患者被分为先天发病和晚期发病两类。晚期发病类别根据发育年龄进一步划分。先天性发病与晚发性PLE的比例为1:4,青少年时期发病率最高。先天性发病组和晚期发病组的性别比例分别为1.04:1和1.5:1。研究发现了三种主要的淋巴异常,其中以淋巴管延迟或部分显示为特征的节段性淋巴功能障碍最为常见,与FLT4、GJC2、CELSR1和PTPN14突变有关。其次是淋巴管增生,这与 FOXC2 和 GATA2 变体有关,然后是初始淋巴管增生或功能障碍,这在先天性 PLE 患者中更为常见,与 FLT4 突变有关。本文提出了淋巴异常的功能和结构综合分类法,包括节段性淋巴功能障碍、淋巴增生和初始淋巴增生或功能障碍。
{"title":"An Updated Classification of Primary Lymphedema Based on Age of Onset, Lymphatic Anomalies, and Genetics.","authors":"N F Liu, M Z Gao, P E Maltese, M Bertelli","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Primary lymphedema (PLE) is a chronic disease caused by lymphatic dysplasia and progresses to irreversible tissue edema and hypertrophy. Understanding of PLE has been hitherto limited. The aim of this study is to devise an updated classification system for PLE of 1013 patients with PLE of lower limb were enrolled. Sex, age of onset, location, family history and morbidity were documented. The lymphatic imaging findings of magnetic reso-nance lymphography (MRL), indocyanine green lymphography (ICGL) and lymphoscin-tigraphy (LSG), skin tissue immunohisto-chemical staining, whole exome sequencing and the correlation of genotype-phenotype were evaluated. Patients were divided into a congenital onset category and a late onset category. The late onset category was further divided according to developmental age. The ratio of congenital-onset to late-onset PLE was 1:4 and that the highest incidence was in adolescence. The sex ratio was 1.04:1 and 1.5:1 in congenital-onset and late-onset groups, respectively. Three major lymphatic anomalies were identified, in which segmental lymphatic dysfunction, characterized by delayed or partial demonstration of lymph vessels, is the most common and associated with FLT4, GJC2, CELSR1, and PTPN14 mutations. The next most common type is lymphatic hyperplasia, which is associated with FOXC2 and GATA2 variants, followed by initial lymphatic aplasia or dysfunction, which is more common in pa-tients with congenital PLE and associated with FLT4 mutation. A functional and structural combined classification of lymphatic anomalies is proposed, which includes segmental lymphatic dysfunction, lymphatic hyperplasia and initial lymphatic aplasia or dysfunction.</p>","PeriodicalId":94343,"journal":{"name":"Lymphology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141428644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addition of Intermittent Pneumatic Compression to Conventional Treatment Improves Volume Reduction Before Lymphatic Surgery for Lower Limb Lymphedema: A Pilot Study. 在常规治疗的基础上增加间歇性气压疗法可改善下肢淋巴水肿手术前的体积缩小效果:试点研究。
Pub Date : 2023-01-01
C C Campisi, E Parodi, A Demoro, R Risso, W D Brinda, C Campisi

This study assesses the impact of an advanced intermittent pneumatic compression device (IPC - Lympha Press® Optimal Plus) when added to Complete Decongestive Therapy (CDT) compared to CDT alone on volume reduction of limbs with lymphedema. The goal is to maximally reduce edema in preparation for microsurgery. Fifty subjects scheduled for Multiple Lymphatic-Venous Anastomosis (MLVA) were randomly (sequentially) assigned to experimental or control group: 25 (21 females and 4 males) in the experimental IPC group and 25 (20 females and 5 males) in the control group. The two groups were similar in age, sex distribution, and type of lymphedema. Results indicate the IPC group reported greater volume loss than the control group (p= 0.00137) comparing final vs. initial limb volume. The average percentage edema volume loss achieved with added IPC was two times greater (11.7%) than in the control group (5.0%). When differences in treatment duration were accounted for, the IPC group achieved consistently greater proportional volume loss (12.83% vs 6.30%) than conservative therapy alone. In our pilot study, IPC added to CDT resulted in greater proportional volume loss and provides better preparation for MLVA surgery.

这项研究评估了先进的间歇性气动加压装置(IPC - Lympha Press® Optimal Plus)与单纯的完全缓解充血疗法(CDT)相比,在完全缓解充血疗法中加入间歇性气动加压装置对减少淋巴水肿肢体体积的影响。目的是最大限度地减轻水肿,为显微手术做好准备。计划进行多淋巴管-静脉吻合术(MLVA)的 50 名受试者被随机(按顺序)分配到实验组或对照组:实验组 IPC 25 人(21 名女性和 4 名男性),对照组 IPC 25 人(20 名女性和 5 名男性)。两组的年龄、性别分布和淋巴水肿类型相似。结果表明,对比最终肢体体积和初始肢体体积,IPC 组比对照组的水肿体积减少得更多(P= 0.00137)。添加IPC后,水肿体积减少的平均百分比(11.7%)是对照组(5.0%)的两倍。如果考虑到治疗持续时间的差异,IPC 组的水肿体积减少比例(12.83% vs 6.30%)始终高于单纯的保守疗法。在我们的试点研究中,在 CDT 的基础上加用 IPC 可使体积按比例缩小,为 MLVA 手术做更好的准备。
{"title":"Addition of Intermittent Pneumatic Compression to Conventional Treatment Improves Volume Reduction Before Lymphatic Surgery for Lower Limb Lymphedema: A Pilot Study.","authors":"C C Campisi, E Parodi, A Demoro, R Risso, W D Brinda, C Campisi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This study assesses the impact of an advanced intermittent pneumatic compression device (IPC - Lympha Press® Optimal Plus) when added to Complete Decongestive Therapy (CDT) compared to CDT alone on volume reduction of limbs with lymphedema. The goal is to maximally reduce edema in preparation for microsurgery. Fifty subjects scheduled for Multiple Lymphatic-Venous Anastomosis (MLVA) were randomly (sequentially) assigned to experimental or control group: 25 (21 females and 4 males) in the experimental IPC group and 25 (20 females and 5 males) in the control group. The two groups were similar in age, sex distribution, and type of lymphedema. Results indicate the IPC group reported greater volume loss than the control group (p= 0.00137) comparing final vs. initial limb volume. The average percentage edema volume loss achieved with added IPC was two times greater (11.7%) than in the control group (5.0%). When differences in treatment duration were accounted for, the IPC group achieved consistently greater proportional volume loss (12.83% vs 6.30%) than conservative therapy alone. In our pilot study, IPC added to CDT resulted in greater proportional volume loss and provides better preparation for MLVA surgery.</p>","PeriodicalId":94343,"journal":{"name":"Lymphology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140856454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Fate of Implanted BioBridgetm Collagen Matrix - Findings in Histology, Scanning, and Transmission Electron Microscopy. 植入的 BioBridgetm 胶原基质的命运--组织学、扫描和透射电子显微镜的发现。
Pub Date : 2023-01-01
M Witt, A Ring, I Stricker, E Fruth

The technique of lymphangioplasty or capillary thread drainage was historically performed with subcutaneously implanted surgical threads. It has recently been revived by introducing a thread-like aligned nanofibrillar collagen matrix (BioBridgetm). These collagen threads consitute subcutaneous neocollectors along which guided lymphangiogenesis is said to occur secondarily. We present for the first time a tissue examination of a 10-month implanted BioBridgetm sample with surrounding tissue from a human subject by histology, scanning and transmission electron microscopy.

淋巴管成形术或毛细血管线引流术在历史上是通过皮下植入手术线来完成的。最近,通过引入线状排列的纳米纤维胶原基质(BioBridgetm),这种技术又重新焕发了生机。这些胶原蛋白线构成了皮下新导管,据说引导淋巴管生成会沿着这些新导管发生。我们首次展示了通过组织学、扫描和透射电子显微镜对植入 BioBridgetm 10 个月的人体样本及其周围组织进行的组织检查。
{"title":"The Fate of Implanted BioBridge<sup>tm</sup> Collagen Matrix - Findings in Histology, Scanning, and Transmission Electron Microscopy.","authors":"M Witt, A Ring, I Stricker, E Fruth","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The technique of lymphangioplasty or capillary thread drainage was historically performed with subcutaneously implanted surgical threads. It has recently been revived by introducing a thread-like aligned nanofibrillar collagen matrix (BioBridge<sup>tm</sup>). These collagen threads consitute subcutaneous neocollectors along which guided lymphangiogenesis is said to occur secondarily. We present for the first time a tissue examination of a 10-month implanted BioBridge<sup>tm</sup> sample with surrounding tissue from a human subject by histology, scanning and transmission electron microscopy.</p>","PeriodicalId":94343,"journal":{"name":"Lymphology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141428648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modified Lymphoscintigraphy in Primary Lymphatic Insufficiency of the Lower Limb. 原发性下肢淋巴功能不全的改良淋巴管造影术
Pub Date : 2023-01-01
M Wald, J Svobodova, H Krizova

Primary lymphedema of the foot and toes could be sometimes misdiagnosed by lymphoscintigraphy as a whole lower limb lymphatic insufficiency (LLLI). This is caused by using standard lymphoscintigraphic protocol based on one interstitial injection of radiotracer applied into the first interdigital space followed by image analysis of lower limb lymphatic vessels and lymph nodes. Here, we show that a modification of the lymphoscintigraphic protocol and introduction of a second dose of radiotracer right above the inner ankle to the clinically healthy tissue can more accurately describe morphological abnormalities of the superficial lymphatic system at the lower limb and thereby refine the diagnosis of the LLLI. Fourteen patients with swelling of the foot and toes (16 lower limbs) were examined using standard lymphoscintigraphic protocol. Subsequently, modified lymphoscintigraphy was performed. While standard lymphoscintigraphy showed severe lymphatic insufficiency of the superficial lymphatic system in all 14 patients (in 16 lower limbs), including significantly reduced number of inguinal nodes, modified lymphoscintigraphy revealed almost normal morphology of superficial lymphatic vessels in 11 patients (in 13 lower limbs) throughout the entire lower limb proximal to the application site. In conclusion, using the modified lymphoscintigraphy protocol in patients with foot and toes primary lymphedema can refine diagnosis and follow-up medical management.

淋巴管造影有时会将脚和脚趾的原发性淋巴水肿误诊为整个下肢淋巴功能不全(LLLI)。造成这种情况的原因是采用了标准的淋巴管造影方案,即在第一趾间间隙注射一次放射性示踪剂,然后对下肢淋巴管和淋巴结进行图像分析。在这里,我们展示了对淋巴管造影方案的修改,在内踝正上方的临床健康组织中注入第二剂量的放射性示踪剂,可以更准确地描述下肢浅表淋巴系统的形态异常,从而完善 LLLI 的诊断。我们采用标准淋巴管造影方案对 14 名足趾肿胀患者(16 名下肢患者)进行了检查。随后进行了改良淋巴管造影。标准淋巴管造影显示所有 14 名患者(16 个下肢)的浅表淋巴系统严重淋巴功能不全,包括腹股沟结节数量明显减少,而改良淋巴管造影显示 11 名患者(13 个下肢)整个下肢近端施术部位的浅表淋巴管形态基本正常。总之,在足趾原发性淋巴水肿患者中使用改良淋巴管造影方案可以完善诊断和后续医疗管理。
{"title":"Modified Lymphoscintigraphy in Primary Lymphatic Insufficiency of the Lower Limb.","authors":"M Wald, J Svobodova, H Krizova","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Primary lymphedema of the foot and toes could be sometimes misdiagnosed by lymphoscintigraphy as a whole lower limb lymphatic insufficiency (LLLI). This is caused by using standard lymphoscintigraphic protocol based on one interstitial injection of radiotracer applied into the first interdigital space followed by image analysis of lower limb lymphatic vessels and lymph nodes. Here, we show that a modification of the lymphoscintigraphic protocol and introduction of a second dose of radiotracer right above the inner ankle to the clinically healthy tissue can more accurately describe morphological abnormalities of the superficial lymphatic system at the lower limb and thereby refine the diagnosis of the LLLI. Fourteen patients with swelling of the foot and toes (16 lower limbs) were examined using standard lymphoscintigraphic protocol. Subsequently, modified lymphoscintigraphy was performed. While standard lymphoscintigraphy showed severe lymphatic insufficiency of the superficial lymphatic system in all 14 patients (in 16 lower limbs), including significantly reduced number of inguinal nodes, modified lymphoscintigraphy revealed almost normal morphology of superficial lymphatic vessels in 11 patients (in 13 lower limbs) throughout the entire lower limb proximal to the application site. In conclusion, using the modified lymphoscintigraphy protocol in patients with foot and toes primary lymphedema can refine diagnosis and follow-up medical management.</p>","PeriodicalId":94343,"journal":{"name":"Lymphology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncolymphology: Immune Interactions and Cancer. 肿瘤淋巴:免疫相互作用与癌症。
Pub Date : 2023-01-01
S P Leong

The proposed term "oncolymphology" encompasses the intimate relationship between cancer growth and the immune responses.

提出的术语“肿瘤淋巴学”包含了癌症生长和免疫反应之间的密切关系。
{"title":"Oncolymphology: Immune Interactions and Cancer.","authors":"S P Leong","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The proposed term \"oncolymphology\" encompasses the intimate relationship between cancer growth and the immune responses.</p>","PeriodicalId":94343,"journal":{"name":"Lymphology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of Inguinal Lymph Node Number and Volume with Lower Extremity Lymphedema Severity. 腹股沟淋巴结数量和体积与下肢淋巴水肿严重程度的相关性
Pub Date : 2023-01-01
M Adondakis, H Ali, B P Salehi, R Friedman, W Sun, K Donohoe, G Kim, D Singhal, L L Tsai, J Weinstein

There are very limited studies on the relationship of inguinal lymph node number and volume correlated with lower extremity lymphedema severity. In this IRB-approved retrospective study, patients who obtained an MRI for lower extremity lymphedema and who did not have lymph node resection or biopsy were identified. The MRI images were used to determine the number and volume of inguinal lymph nodes for each limb in addition to fat and fluid-based scoring using a validated grading system. Wilcoxon signed-rank tests were used to compare the greater-affected limbs with the lesser-affected limbs. The spear-man-rank correlation was performed on a 'per limb' basis for MRI-based scoring and clinical parameters with ipsilateral lymph node number and volume and for differences between the limbs. A total of 32 patients were included. The greater-affected limb had higher MRI fluid scores (median (interquartile range) = 3 (3 - 3) vs. 0 (0 - 1), (p < 0.01) relative to the contra-lateral limb and had a median fat asymmetry score of 2 (1 - 3). On the per-limb analysis, lymph node number and volume inversely correlated with total MRI scores (ρ = -0.47, p < 0.01 for node number and volume). The difference of lymph node number and volume correlated with MRI score difference (node number: ρ = -0.66, p < 0.01; node volume: ρ = -0.64, p < 0.01) and perometer difference (node number: ρ = -0.58, p < 0.01; node volume: ρ = -0.59, p < 0.01). Inguinal lymph node number and volume inversely correlate with lower extremity edema presence and severity.

关于腹股沟淋巴结数量和体积与下肢淋巴水肿严重程度之间关系的研究非常有限。在这项经 IRB 批准的回顾性研究中,确定了因下肢淋巴水肿而接受 MRI 检查但未进行淋巴结切除或活检的患者。核磁共振成像图像用于确定每个肢体腹股沟淋巴结的数量和体积,此外还使用经过验证的分级系统对脂肪和液体进行评分。Wilcoxon 符号秩检验用于比较受影响较大的肢体和受影响较小的肢体。矛-人-秩相关性是以 "每个肢体 "为基础,对基于核磁共振成像的评分和临床参数与同侧淋巴结数量和体积以及肢体之间的差异进行分析。共纳入 32 名患者。相对于对侧肢体,受影响较大的肢体的 MRI 液体评分更高(中位数(四分位间范围)= 3 (3 - 3) vs. 0 (0 - 1),(p < 0.01),脂肪不对称的中位数评分为 2 (1 - 3)。在每肢分析中,淋巴结数量和体积与 MRI 总分成反比(ρ = -0.47,淋巴结数量和体积的 p < 0.01)。淋巴结数量和体积的差异与 MRI 评分差异(结节数量:ρ = -0.66,p < 0.01;结节体积:ρ = -0.64,p < 0.01)和周长差异(结节数量:ρ = -0.58,p < 0.01;结节体积:ρ = -0.59,p < 0.01)相关。腹股沟淋巴结数量和体积与下肢水肿的存在和严重程度成反比。
{"title":"Correlation of Inguinal Lymph Node Number and Volume with Lower Extremity Lymphedema Severity.","authors":"M Adondakis, H Ali, B P Salehi, R Friedman, W Sun, K Donohoe, G Kim, D Singhal, L L Tsai, J Weinstein","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>There are very limited studies on the relationship of inguinal lymph node number and volume correlated with lower extremity lymphedema severity. In this IRB-approved retrospective study, patients who obtained an MRI for lower extremity lymphedema and who did not have lymph node resection or biopsy were identified. The MRI images were used to determine the number and volume of inguinal lymph nodes for each limb in addition to fat and fluid-based scoring using a validated grading system. Wilcoxon signed-rank tests were used to compare the greater-affected limbs with the lesser-affected limbs. The spear-man-rank correlation was performed on a 'per limb' basis for MRI-based scoring and clinical parameters with ipsilateral lymph node number and volume and for differences between the limbs. A total of 32 patients were included. The greater-affected limb had higher MRI fluid scores (median (interquartile range) = 3 (3 - 3) vs. 0 (0 - 1), (p < 0.01) relative to the contra-lateral limb and had a median fat asymmetry score of 2 (1 - 3). On the per-limb analysis, lymph node number and volume inversely correlated with total MRI scores (ρ = -0.47, p < 0.01 for node number and volume). The difference of lymph node number and volume correlated with MRI score difference (node number: ρ = -0.66, p < 0.01; node volume: ρ = -0.64, p < 0.01) and perometer difference (node number: ρ = -0.58, p < 0.01; node volume: ρ = -0.59, p < 0.01). Inguinal lymph node number and volume inversely correlate with lower extremity edema presence and severity.</p>","PeriodicalId":94343,"journal":{"name":"Lymphology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Lymphology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1